# Prenatal DHA and Neurofunctional Development

> **NCT02709239** · NA · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 300 (actual)

## Conditions studied

- Use and Dose of Prenatal DHA Supplementation

## Interventions

- **DIETARY_SUPPLEMENT:** DHA 200mg
- **DIETARY_SUPPLEMENT:** DHA 800mg

## Key facts

- **NCT ID:** NCT02709239
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2020-08-20
- **Final completion:** 2021-08-16
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2021-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709239, "Prenatal DHA and Neurofunctional Development". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02709239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*